Affinity Asset Advisors »

Avrobio Ord shares owned by Affinity Asset Advisors

Quarter-by-quarter ownership of Avrobio Ord (AVRO) shares owned by Affinity Asset Advisors from 13F filings

Historical chart of Affinity Asset Advisors investment in Avrobio Ord

Tip: Access up to 7 years of quarterly data

All positions including Avrobio Ord held by Affinity Asset Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avrobio Ord by Affinity Asset Advisors

Quarter filed Position value Share count Share price at filing
2023-09-30 $770k 500k 1.54

More positions owned by Affinity Asset Advisors

Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Apogee Therapeutics (APGE)
Establishment Labs Holdings Ord (ESTA)
Cymabay Therapeutics
Immunovant (IMVT)
Bridgebio Pharma Note 2.500% 3/1 (Principal)
Cerevel Therapeutics Hldng I (CERE)
Arcellx Common Stock (ACLX)
Crinetics Pharmaceuticals In (CRNX)
Madrigal Pharmaceuticals (MDGL)
Xenon Pharmaceuticals (XENE)
Alkermes SHS Call Option (ALKS)
Kura Oncology (KURA)
Astria Therapeutics (ATXS)
Morphic Hldg (MORF)

View all positions for Affinity Asset Advisors

Top funds holding Avrobio Ord

Atlas Venture Life Science Advisors
BML Capital Management
Newtyn Management
Vanguard Group
Aisling Capital Management
Ikarian Capital
Vazirani Asset Management
Citadel Advisors
FNY Investment Advisers
Western Standard
Two Sigma Investments
Two Sigma Advisers
Wells Fargo & Company
ADAR1 Capital Management
Barclays

View all funds holding Avrobio Ord